Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$8.72K Buy
+232
New +$8.29K ﹤0.01% 584
2023
Q4
Sell
-297
Closed -$11.2K 705
2023
Q3
$11.2K Sell
297
-59
-17% -$2.4K ﹤0.01% 572
2023
Q2
$14.5K Hold
356
﹤0.01% 559
2023
Q1
$14.9K Sell
356
-154
-30% -$6.42K ﹤0.01% 589
2022
Q4
$22K Sell
510
-504
-50% -$19.9K ﹤0.01% 550
2022
Q3
$38K Sell
1,014
-68
-6% -$3.01K ﹤0.01% 482
2022
Q2
$49K Sell
1,082
-397
-27% -$18.7K ﹤0.01% 485
2022
Q1
$70K Sell
1,479
-2,189
-60% -$92.7K ﹤0.01% 483
2021
Q4
$151K Buy
+3,668
New +$138K ﹤0.01% 373

Other funds holding EXC

Cambridge Trust's EXC Position: Q1 2024 in Review

Cambridge Trust opened a new position in Exelon (EXC) in Q1 2024: 232 shares worth $8.72K. The stake represents ﹤0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: Cambridge Trust previously reported a position in EXC as recently as Q3 2023.

Cambridge Trust first reported a position in EXC in Q4 2021 and has held it in 9 quarters since. The position peaked at $151K in Q4 2021. 1,009 funds tracked by Wall St. Rank hold EXC as of Q1 2024.

  • Cambridge Trust held 232 shares of Exelon worth $8.72K as of Q1 2024.
  • Exelon was a new Cambridge Trust position in Q1 2024.
  • Exelon made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #584 holding.
  • Cambridge Trust first reported a position in Exelon in Q4 2021 and has held it in 9 quarters since.
  • Cambridge Trust's Exelon position peaked at $151K in Q4 2021.
  • 1,009 funds tracked by Wall St. Rank held Exelon as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.